Last updated: December 4, 2024
Sponsor: Gainesville Eye Associates
Overall Status: Active - Recruiting
Phase
4
Condition
Glaucoma
Treatment
Visual field assessment
Clinical Study ID
NCT06539715
CB-24-01
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adult patients with best-corrected visual outcomes of 20/30 or better.
Exclusion
Exclusion Criteria:
Unable to tolerate ophthalmic imaging
Any ocular or systemic conditions, that could affect VF test results, such asage-related macular degeneration, peripheral retinal disease, or severe glaucoma.
The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.
Study Design
Total Participants: 54
Treatment Group(s): 1
Primary Treatment: Visual field assessment
Phase: 4
Study Start date:
November 18, 2024
Estimated Completion Date:
November 25, 2025
Connect with a study center
North Georgia Eye Associates
Gainesville, Georgia 30501
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.